ABSTRACT FORMAT AND CONTENT:

Language: English

Presentation title: The title of the abstract should not exceed 30 words. Capitalize only the first letter of the first word of the title (unless for abbreviations or proper nouns) and do not end the title with a period (.).

Author(s): Include the first name and last name of each author in the order of their contribution and include their affiliation including city and country. 

Main text: The main body of the abstract should not exceed 5,000 characters with spaces. Separate the main abstract text by subheadings into Introduction, Methods, Results, Conclusions. 

Presentation method: Choose the preferred presentation mode: oral or poster. Once submitted all abstracts will be reviewed by international scientific committee; however, only a limited number of oral-preference abstracts can be considered. The remainder will be evaluated for poster presentations. If you are not comfortable with presenting and responding to questions in English, you are encouraged to present a poster.

Abstract publishing: Accepted abstracts will be published as an online PDF abstract book and will not be printed. The abstract book will have an ISSN.

Authorts' certification: The abstract must contain primary scientific or clinical data that have not been published elsewhere. 
The abstract submitter is responsible for ensuring that all authors have read the abstract and agreed to be co-authors.
Submitted abstracts on human subjects must have ethical approval and state whether informed consent was obtained. Animal studies need to be approved by the relevant animal use committees.

NOTE! Before submitting your abstract, please carefully review the information, and pay particular attention to grammar, authors' names, and affiliations. The content will be published in the event's proceedings exactly as submitted.

ABSTRACT SUBMISSION

Presentation title*
Category*
0.00
0.00
Please indicate a topic preference for your abstract:
Preference:*0.00

Presenting author's data

First name*
Last name*
Job title*(e.g. Professor, Lecturer, PhD Student etc.)
Affiliation (Organisation/Institution)*
Presenting author's e-mail address*
Country*

Corresponding author's data

First name*
Last name*
Corresponding author's e-mail address*
Abstract (please paste the text here)*5000Required structure: 
  • Abstract should include following paragraphs 
  • Intoduction 
  • Materials and Methods 
  • Results and Discussion 
  • Conclusion  
  • Acknowledgments
NB! The text must be structured into the mentioned paragraphs and must include these subtitles for the paragraphs! 
The maximum number of characters together with spaces is 5000.

It is particularly important that you state clearly what you have done, not merely what you plan to do, and explain how your work is different from previously published work, i.e., what is the unique contribution that your work makes to the field? Please consider what the reader will learn from your submission, and how they will find your work useful. If you write with these questions in mind, your work is more likely to be successful, both in being accepted into the Conference, and in influencing the work of our field. After the Conclusion part you can also use a paragraph with Acknowledgements, for example if you want to thank funding sources or supporters of your work.  
Please write the co-authors' names here together with their affiliations.Formatting: last name, first name, institution (e.g. John Smith, University of Tartu)
Keywords (up to 6)
References (up to 5)*

REFERENCES STYLE GUIDE

Use a numbered list of references at the end of the article, ordered as they appear in the text or ordered alphabetically by first author. Your references should be published materials accessible to the public. Proprietary information may not be cited. Private communication should be acknowledged in the main text, not referenced (e.g., “[Robertson, personal communication]”). 
Examples:

  1. Chien, Y.W. Human insulin: Basic sciences to therapeutic uses, Drug Dev. Ind. Pharm. 22, 753-789 (1996). 

  1. Carino, G. and Mathiowitz, E. Oral insulin delivery, Adv. Drug Del. Rev. 35, 249-257 (1999). 

  1. Elsayed, A.; Al Remawi, M.; Qinna, N.; Farouk, A. and Badwan, A. Formulation and characterization of an oily-based system for oral delivery of insulin. Euro. J. Pharm. Biopharm., 73, 269-279 (2009). 

  1. Remawi, M.; Badwan, A Qinna, N.; Elsayed, Arafat, A.; Melhim, M.; Abu Hijleh, O. and Idkaidek, N. Enhancement of oral bioavailability of insulin in humans. Neuroendocrinology Letters, 30, 101-105 (2009). 

*